Birchview Capital, LP Incresed Positions in Q3 2024

Birchview Capital, LP

  • $108 Million
  • Q3 2024
Stock Shares change Price Range Shares Held Trade History
ACAD
Acadia Pharmaceuticals Inc

Healthcare
150K
+ 59.9%
$15.14 - $19.14 $2.27M - $2.87M
400K $6.16M
TVTX
Travere Therapeutics, Inc.

Healthcare
26K
+ 21.31%
$7.89 - $15.21 $205K - $395K
148K $2.07M
CSTL
Castle Biosciences Inc

Healthcare
24K
+ 70.59%
$17.4 - $31.47 $418K - $755K
58K $1.65M
KALV
Kal Vista Pharmaceuticals, Inc.

Healthcare
36K
+ 78.26%
$9.46 - $15.39 $341K - $554K
82K $949K
DCGO
Doc Go Inc.

Healthcare
55K
+ 11.96%
$2.84 - $3.78 $156K - $208K
515K $1.71M
ATEC
Alphatec Holdings, Inc.

Healthcare
110K
+ 125.0%
$5.45 - $11.87 $600K - $1.31M
198K $1.1M
Inhibrx Biosciences Inc
20K
+ 165.15%
N/A
32.1K $0
CHRS
Coherus Bio Sciences, Inc.

Healthcare
102K
+ 37.78%
$0.99 - $1.8 $101K - $184K
372K $386K
PRTA
Prothena Corp Public LTD CO

Healthcare
6K
+ 2.95%
$16.73 - $24.79 $100K - $149K
210K $3.51M
Activity Summary
Buys All Purchases 14 New Holdings 5 Increased Positions 9 Sells All Sells 7 Reductions 7 Sold out 0 Options Calls 0 Puts 0
Track This Portfolio

Track Birchview Capital, LP Portfolio

Follow Birchview Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birchview Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birchview Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email